Myungin Pharm명인제약
317450 · KOSPI · ₩317450 · 명인제약
₩40,200▲ ₩300 (0.75%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | |
|---|---|---|
| Gross margin | 60.6% | 60.6% |
| Operating margin | 32.2% | 32.2% |
| Net margin | 28.3% | 28.3% |
Growth (year on year)
| TTM | 2025 | |
|---|---|---|
| Revenue growth | 0.0% | — |
| Operating income growth | 0.0% | — |
| Net income growth | 0.0% | — |
Returns
| TTM | 2025 | |
|---|---|---|
| Return on equity | 10.1% | 10.3% |
| Return on assets | 9.5% | 9.7% |
Leverage and liquidity
| TTM | 2025 | |
|---|---|---|
| Liabilities to equity | 6.4% | 6.0% |
| Net debt to equity | — | — |
| Current ratio | 1,240.1% | 1,392.9% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Myungin Pharm / 명인제약 / 317450 / KRX:317450
Source: KRX statistical information